These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3677334)

  • 1. Role of adrenal steroids in the recovery from platelet activating factor challenge.
    Myers AK; Bader TJ
    Circ Shock; 1987; 23(2):143-50. PubMed ID: 3677334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a platelet-activating factor antagonist, CV-3988, on different shock models in the rat.
    Toth PD; Mikulaschek AW
    Circ Shock; 1986; 20(3):193-203. PubMed ID: 3802423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative hemodynamics and cardiovascular effects of endotoxin and platelet-activating factor in rat.
    Salari H; Demos M; Wong A
    Circ Shock; 1990 Nov; 32(3):189-207. PubMed ID: 2261677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441.
    Handley DA; Tomesch JC; Saunders RN
    Thromb Haemost; 1986 Aug; 56(1):40-4. PubMed ID: 3775689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice.
    Sun XM; Hsueh W
    J Immunol; 1991 Jul; 147(2):509-14. PubMed ID: 2071893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage inflammatory protein-2 mediates the bowel injury induced by platelet-activating factor.
    Han XB; Liu X; Hsueh W; De Plaen IG
    Am J Physiol Gastrointest Liver Physiol; 2004 Dec; 287(6):G1220-6. PubMed ID: 15319184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of endotoxin-induced increase in glucose metabolism by platelet-activating factor antagonist.
    Lang CH; Dobrescu C; Hargrove DM; Bagby GJ; Spitzer JJ
    Circ Shock; 1987; 23(3):179-88. PubMed ID: 3427772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of platelet-activating factor during traumatic shock.
    Stahl GL; Craft DV; Lento PH; Lefer AM
    Circ Shock; 1988 Nov; 26(3):237-44. PubMed ID: 3208421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of sympathetic nervous system in hypotension induced by platelet-activating factor in anesthetized dogs.
    Matsuda Y; Shibamoto T; Sawano F; Saeki Y; Hayashi T; Kawamoto M; Koyama S
    Circ Shock; 1993 Mar; 39(3):188-93. PubMed ID: 8453742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of dexamethasone in endotoxic shock and its relation to PAF-acether synthesis in the gastrointestinal tract and lung.
    Ibbotson GC; Wallace JL
    J Lipid Mediat; 1989; 1(5):273-82. PubMed ID: 2519897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
    Natsume Y; Imanishi N; Koike H; Morooka S
    Arzneimittelforschung; 1994 Nov; 44(11):1208-13. PubMed ID: 7848333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenalectomy blocks pressor responses to naloxone in endotoxic shock: evidence for sympathomedullary involvement.
    Holaday JW; D'Amato RJ; Ruvio BA; Feuerstein G; Faden AI
    Circ Shock; 1983; 11(3):201-10. PubMed ID: 6317225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of PAF-acether in the anaphylactic shock in the rat.
    Damas J
    J Lipid Mediat; 1989; 1(3):161-70. PubMed ID: 2519891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone.
    Feuerstein G; Lux WE; Snyder F; Ezra D; Faden AI
    Circ Shock; 1984; 13(3):255-60. PubMed ID: 6432359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a role of platelet activating factor in hypovolemic shock in the rat.
    Zingarelli B; Squadrito F; Bussolino F; Calapai G; Altavilla D; Ioculano M; Campo GM; Canale P; Caputi AP
    J Lipid Mediat Cell Signal; 1994 Mar; 9(2):123-34. PubMed ID: 8012759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming by platelet-activating factor of endotoxin-induced lung injury and cardiovascular shock.
    Rabinovici R; Esser KM; Lysko PG; Yue TL; Griswold DE; Hillegass LM; Bugelski PJ; Hallenbeck JM; Feuerstein G
    Circ Res; 1991 Jul; 69(1):12-25. PubMed ID: 1647275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the platelet activating factor (PAF)-induced in vivo responses in rats by trans-2,5-(3,4,5-trimethoxyphenyl) tetrahydrofuran (L-652,731), a PAF receptor antagonist.
    Wu MS; Biftu T; Doebber TW
    J Pharmacol Exp Ther; 1986 Dec; 239(3):841-5. PubMed ID: 3795043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Involvement of platelet activating factors in pathologic leukocyte-endothelium interactions in the liver after hemorrhagic shock].
    Marzi I; Bauer M; Reisdorf E; Walcher F
    Zentralbl Chir; 1994; 119(11):814-21. PubMed ID: 7846961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.